# The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia

> **NCT02415062** · PHASE2 · UNKNOWN · sponsor: **Inje University** · enrollment: 150 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT02415062
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2016-10
- **Final completion:** 2017-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2015-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02415062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02415062, "The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02415062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*